Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Aclaris Therapeutics, Inc.

TRADE

NASDAQ: ACRSHealthcare / Biotechnology / USA
11.99-0.47-3.77%Vol 254 6951Y Perf -54.73%
Oct 17th, 2018 13:46
BID11.98 ASK12.02
Open12.45 Previous Close12.46
Pre-Market12.45 After-Trading12.46
 -0.01 -0.08%  - -%
Target Price
44.33 
Analyst Rating
Strong Buy 1.00
Potencial %
269.73 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/25/33 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/5/57 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/18/65 
Income Ranking
 —    -
Market Cap (mil)371 
Earnings Rating
Sell
Price Range Ratio 52wk %
3.31 
Earnings Date
6th Nov 2018

Today's Price Range

11.4712.45

 

52wk Range

11.4727.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-17.21%
3 Months
-38.01%
6 Months
-31.65%
1 Year
-54.73%
3 Years
-14.48%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACRS11.99-0.4700-3.77
AAPL221.67-0.4800-0.22
GOOG1 117.81-3.4700-0.31
MSFT110.82-0.1800-0.16
XOM81.250.05000.06
WFC54.620.89001.66
JNJ139.613.05002.23
FB159.150.37000.23
GE12.310.21001.74
JPM110.281.66001.53
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 8.30
Current Ratio 8.50
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin48.20
EBIT Margin-1 653.90
EBITDA Margin-1 641.00
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.42
PS Ratios 87.78
Price to Cash Flow -
Price to Free Cash Flow -6.70
Cash Flow Per Share -2.49
Price to Tangible Book2.84
Book Value per Share5.62
Enterprise Value (in ths.)256 665
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-33.62
ROE last 12 Months -59.26
Return on Assets (5Y Avg) -16.84
ROA last 12 Months -53.61
Return on Capital (5Y Avg) -
ROC last 12 Months -59.73
Return on invested Capital Q -16.63
Return on invested Capital Y-34.69
Assets Turnover0.00
Receivables Turnover4.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)4 793
Revenue per Share 0.15
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.95-1.01-6.32
Q01 2018-0.99-0.981.01
Q04 2017-0.90-0.8011.11
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Q01 2017-0.54-0.4811.11
Q04 2016-0.59-0.4916.95
Q03 2016-0.68-0.5026.47
Earnings Per EndEstimateRevision %Trend
9/2018 QR-1.19-7.21Negative
12/2018 QR-1.25-5.93Negative
12/2018 FY-4.60-5.50Negative
12/2019 FY-3.96-16.81Negative
Next Report Date6th Nov 2018
Estimated EPS Next Report-1.19
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume254 695
Shares Outstanding (in ths.)30 980
Trades Count1 416
Dollar Volume2 387 608
Avg. Volume269 503
Avg. Weekly Volume329 492
Avg. Monthly Volume263 698
Avg. Quarterly Volume253 307

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

27%73%

Bearish Bullish

64%36%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
5 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x